Travere Therapeutics to Present at Upcoming Investor Conferences
Travere Therapeutics (NASDAQ: TVTX) will participate in several key healthcare conferences in November and December 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Travere Therapeutics (NASDAQ: TVTX) will participate in several key healthcare conferences in November and December 2022. Key events include:
- Jefferies 2022 London Healthcare Conference on November 16 at 4:25 p.m. GMT.
- 5th Annual Evercore ISI HealthCONx Conference on November 29 at 1:25 p.m. ET.
- Piper Sandler Healthcare Conference on December 1 at 10:30 a.m. ET.
- BofA Securities 2022 Biotech SMID Cap Conference on December 7 at 12:15 p.m. ET.
Live webcasts will be accessible on the company’s website.
Details
News Market Reaction – TVTX
The recorded move for TVTX in the trading session of this news was +8.70%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming conferences:
Jefferies 2022 London Healthcare Conference
Wednesday, November 16, 2022, at 4:25 p.m. GMT (11:25 a.m. ET)
5th Annual Evercore ISI HealthCONx Conference
Tuesday, November 29, 2022, at 1:25 p.m. ET
Piper Sandler Healthcare Conference
Thursday, December 1, 2022, at 10:30 a.m. ET
BofA Securities 2022 Biotech SMID Cap Conference
Wednesday, December 7, 2022, at 12:15 p.m. ET
Live webcasts of the presentations will be accessible on the company’s website, ir.travere.com, under the “Events and Presentations” section. Replays will be available for up to 90 days following each event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com
Contact:
Naomi Eichenbaum
Vice President, Investor Relations
IR@travere.com
888-969-7879
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.